A Phase I Clinical Study to Evaluate the Efficacy and Safety of GB18 Injection in Patients With Tumor Cachexia

Abroad (travel likely)RecruitingPHASE1

Conditions

Cachexia; Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Peking University Cancer Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Lin Shen) · doctorshenlin@sina.com · 010-50847588-889
    Contact: Principal Investigator (Lin Shen)
  • Beijing GoBroad Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Ming Lu) · lum6@gobroadhealthcare.com · 010-50847588-889
    Contact: Principal Investigator (Ming Lu)
    Contact: Principal Investigator (Zhihao Lu)